SEC Form 4/A · accession 0001179110-18-004867
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Ganesh Venkataraman Kaundinya
Officer — COO & CSO
Period of report
Feb 12, 2018
Accepted (ET)
Mar 27, 2018 · 4:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F1,F3 | — | Feb 12, 2018 | A | 50,000 | A | — | — | Common Stock | 50,000 | 50,000 | D |
| Stock Option (Right to Buy)F4 | $7.41 | Feb 12, 2018 | M | 10,103 | D | Feb 22, 2012 | Feb 22, 2018 | Common Stock | 10,103 | 0 | D |
Explanation of responses
- F1Each Restricted Stock Unit represents a contingent right to receive one share of MNTA common stock.
- F2The original Form 4 filed on February 14, 2018 is amended by this Form 4/A to correctly reflect the reporting person's acquisition of 50,000 restricted stock units as an acquisition in Column 5.
- F3Subject to certain criteria, the restricted stock units will vest with respect to 50% of the shares on the first anniversary of the grant date, and the remaining 50% will vest on the second anniversary of the grant date.
- F4The original Form 4 filed on February 14, 2018 is amended by this Form 4/A to correctly reflect the reporting person's exercise of 10,103 stock options as a disposition in Column 5.